Metagenomic sequencing is a laboratory method that can analyse genetic material in a clinical sample without testing only for one preselected organism. In selected complex infections, it may help clinicians investigate bacteria, viruses, fungi or parasites that routine targeted tests have not identified.

This Revitalize health guide explains the method without promoting an outside doctor or hospital, retelling an identifiable patient case or implying that the test is routinely available through a Revitalize treatment package.

How metagenomic testing differs from targeted testing

Targeted PCR looks for genetic material from specified organisms. Metagenomic testing analyses a broader range of material and compares sequences with reference databases. Broader testing can be useful, but it also creates challenges involving contamination, background material, interpretation and uncertain findings.

A detected sequence does not automatically prove that an organism is causing disease. Results must be interpreted alongside symptoms, examination, imaging, conventional microbiology, sample quality and treatment history.

When clinicians may consider it

A specialist team may consider metagenomic testing when an infection is severe, unusual, persistent or unexplained after appropriate standard investigation. Possible settings include selected neurological, respiratory, bloodstream, eye or immunocompromised-patient infections. It is not a screening test for people without a relevant clinical indication.

Why travel and treatment history matter

Clinicians should know about recent and remote travel, animal or water exposure, insect bites, occupation, immune status, previous surgery, implanted devices and antimicrobial treatment. These details can guide conventional testing and help specialists interpret a broad sequencing result.

Limitations and risks

• A sample may contain too little pathogen material or too much human genetic material.
• Contamination can produce misleading signals.
• Reference databases and interpretation methods have limitations.
• A negative result cannot exclude every infection.
• A positive signal may not identify the cause of symptoms.
• Sampling procedures can carry their own clinical risks.

Testing should be requested and interpreted by an appropriate clinical and laboratory team. No test can guarantee a diagnosis, preserve sight or produce a successful treatment outcome.

Eye symptoms need prompt assessment

Sudden loss or reduction of vision, severe eye pain, new flashes or floaters, marked redness, light sensitivity, trauma or chemical exposure requires urgent professional assessment. Contact local emergency or urgent eye services; in the UK, NHS 111 can advise where to obtain appropriate care.

Do not delay urgent investigation while arranging international travel. Complex or unexplained inflammation may require a specialist multidisciplinary opinion before any elective eye procedure is considered.

Revitalize eye-treatment coordination

Revitalize coordinates selected elective pathways after individual assessment. Review the Revitalize eye treatment overview and trifocal lens replacement guide for relevant elective information.

These services should not be interpreted as access to metagenomic testing or treatment for an undiagnosed infection. If a clinician identifies a need for specialist infection testing, the referral route and laboratory must be confirmed separately.

Questions to ask a clinical team

• What standard investigations have already been completed?
• Why might broad sequencing add useful information in this case?
• Which sample is required and what are the sampling risks?
• How are contamination and uncertain findings handled?
• Who will interpret the result and decide whether treatment should change?
• What happens if the result is negative or inconclusive?

Provider and claim verification

Do not rely on a promotional case story, unnamed expert, predicted cost or claim that a technology is a “game-changer.” Confirm the current service, eligibility, laboratory accreditation and referral arrangements with the treating clinician or relevant official health service.

For any elective Revitalize pathway, request the named contracted doctor and hospital in writing. Learn more about Revitalize’s coordination approach.

Frequently asked questions

Can metagenomic sequencing identify every infection?

No. Sample quality, pathogen load, databases and interpretation all affect performance.

Does a positive result prove causation?

No. The finding must be interpreted in clinical context and may require confirmation.

Is the test part of every Revitalize eye assessment?

No. This page is general health information and does not state that metagenomic testing is included or routinely available.

Should urgent eye symptoms wait for travel?

No. Seek appropriate urgent care locally.